Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations.

Saved in:
Bibliographic Details
Title: Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations.
Authors: Yang Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Wang Z; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Xiao T; Department of Clinical Research, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China; and., Ni X; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Song E; Department of Pharmacy, Guangdong North Third People's Hospital, Shaoguan, China., Dai L; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Department of Pharmacy, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Chen Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Lu H; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Shang D; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou., Wen Y; Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou.
Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Dec 12; Vol. 47 (4), pp. 545-550. Date of Electronic Publication: 2024 Dec 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-3694
DOI:10.1097/FTD.0000000000001298